BRIEF-Lilly to Offer All Approved Zepbound Doses via LillyDirect Self-Pay Pharmacy

Reuters
16 Jun
BRIEF-Lilly to Offer All Approved Zepbound Doses via LillyDirect Self-Pay Pharmacy

June 16 (Reuters) - Eli Lilly and Co LLY.N:

  • LILLY TO OFFER ALL APPROVED DOSES OF ZEPBOUND (TIRZEPATIDE) SINGLE-DOSE VIALS THROUGH LILLYDIRECT SELF PAY PHARMACY SOLUTIONS

  • ELI LILLY AND CO - ALL APPROVED ZEPBOUND DOSES AVAILABLE FOR $499/MONTH OR LESS

  • ELI LILLY AND CO - 12.5 MG AND 15 MG ZEPBOUND VIALS AVAILABLE FOR PRESCRIPTION JULY 7

Source text: ID:nPn24xrdSa

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10